4 min read The White House recently announced a deal with two pharmaceutical manufacturers to lower the price of GLP-1 drugs for weight loss
306 Combination strategies using -lipoic acid and hydroxycitrate enhance catabolic metabolism and suppress tumor growth in glioblastoma, brain metastases, and lung cancer
Claims of meaningful human fat loss should therefore be read as unproven hypotheses , not established outcomes
Cersosimo E, Alatrach M, Solis-Herrera C, et al
Its important to note, however, that compounded versions of the drugs arent approved by the U.S
In these trials, which had similar designs and included populations enriched for subjects at high risk for cardiovascular (CV) events [13, 26], there were fewer major adverse CV events (MACE, defined as death from CV causes, non-fatal myocardial infarction [MI] or non-fatal stroke) with semaglutide vs placebo: the hazard ratios were similar for s.c